Biomab Egfr
Biomab Egfr Uses, Dosage, Side Effects, Food Interaction and all others data.
Trade Name | Biomab Egfr |
Generic | Nimotuzumab |
Nimotuzumab Other Names | Nimotuzumab |
Weight | 50mg |
Type | Injection |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | Biocon Ltd |
Available Country | India |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Biomab Egfr is an EGFR-targeting monoclonal antibody used in the treatment of squamous cell carcinomas of the head and neck and glioblastomas.
Investigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.
Biomab Egfr is also used to associated treatment for these conditions: Advanced Head and Neck Cancer, Advanced Stage Head and Neck Cancer, Glioblastoma Multiforme (GBM), High Grade Glioma (HGG), Advanced Epithelial Tumor of the Head and Neck
Innovators Monograph
You find simplified version here Biomab Egfr